CARLOS ORTIZ: Open Payments
NPI 1457702482 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$528 in 19 payments from 11 companies in 2025. Trend: 2023 $2,203 · 2024 $1,349 · 2025 $528
Food & beverage: $528
| Company | Payments | Amount |
|---|---|---|
| Kestra Medical Technology Services, Inc. | 4 | $145 |
| CVRx, Inc. | 1 | $87 |
| Novartis Pharmaceuticals Corporation | 3 | $66 |
| Abbott Laboratories | 2 | $45 |
| PFIZER INC. | 1 | $35 |
| Amgen Inc. | 2 | $31 |
| E.R. Squibb & Sons, L.L.C. | 2 | $28 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $24 |
| SCPHARMACEUTICALS INC. | 1 | $23 |
| AtriCure, Inc. | 1 | $23 |
Products named: Assure WCD, Barostim Neo System, LEQVIO, AMPLATZER AMULET, ELIQUIS, REPATHA, CAMZYOS, LifeVest.
Industry payments across FL — which companies pay providers there.
